Caesar J. Belbel
EXECUTIVE VICE PRESIDENT, CHIEF OPERATING OFFICER,
United States of America
Mr. Belbel joined Ziopharm Oncology in September 2011 as Executive Vice President and Chief Legal Officer, and in June 2015 he was appointed to the additional position of Chief Operating Officer. He has substantial experience in corporate operations and expertise in the areas of corporate and securities law. As a corporate lawyer, Mr. Belbel has represented numerous public and private companies in a wide range of rapidly growing industries, including life sciences, biotechnology, software, internet services and venture capital. He has been a member of the executive committee of four public companies and has gained extensive experience in all corporate operational and legal matters including mergers, acquisitions and divestitures; complex financing transactions; securities law; corporate governance; regulatory affairs and investigations; licensing and intellectual property protection and transfer; and litigation strategy and management. Prior to joining Ziopharm, from 2003 to 2011, he was Executive Vice President and Chief Legal Officer of Clinical Data, Inc., a biopharmaceutical company which was acquired in April 2011 by Forest Laboratories, Inc. At Clinical Data, Mr. Belbel led the transformation of the company through numerous mergers, acquisitions, divestitures and public and private financings, from a traditional diagnostics company to the developer of genetic diagnostics and novel small molecule therapeutics, including Viibryd, which was approved by the FDA in January 2011 for the treatment of depression. Prior to Clinical Data, he served in senior management and as the top legal executive of a publicly held internet services provider, a privately held software company acquired by Compuware Corporation, and a customer support management software company taken public under Mr. Belbel's leadership. Mr. Belbel also practiced as a corporate attorney in the emerging companies practice groups of Testa, Hurwitz & Thibeault, and McDermott, Will & Emery. He a graduate of Columbia University and Boston College Law School.
Genetic diagnostics and novel small molecule therapeutics